Welcome to Breakpoint, a daily look at an ever-changing culture through the lens of

unchanging truth, with the Colson Center on John Stone Street.

A common claim by those who advocate for so-called gender-affirming care is that the effects of the treatments,

especially puberty blockers, are reversible. These drugs are simply a way, advocates claim,

for gender-confused teens to push pause on puberty and buy more time so they can find out who they really are.

At any time, they can just stop taking the drugs and resume puberty without any consequences.

One group that's long made this claim is the World Professional Association for Transgender Health or W Path, the leading transgender medical organization in the world, in its standards of care, which have become the definitive protocol for so-called gender affirming care,

W-path claims that puberty blocking drugs which are supposed to reduce distress stemming

from physical changes that occur when puberty begins are fully reversible.

However, recently, in a video leaked from W Path's September 2022 certification seminar,

the truth came out.

According to W-PATH certified,

Pediatric endocrinologist Dr. Daniel Metzker,

puberty-blocking drugs aren't as reversible or non-invasive as advocates have claimed.

In fact, they interrupt teens physical developments in ways that cannot be reversed.

For example, puberty blocking drugs decrease bone density,

as Metzker noted, and I quote,

normally puberty is the time of putting the calcium into your piggy bank.

Puberty blockers slow that calcium accrual

back to pre-Pubertal levels.

Those who take puberty blockers

and then either continue with normal pubertile development or go on to quote-unquote transition,

...